by John Conrad | Feb 5, 2024 | iBIO News
We are thrilled to announce the official launch of the application portal for the inaugural Timothy P. Walbert Entrepreneurship Impact Award Competition. This prestigious award competition, organized by iBIO, is a tribute to Timothy P. Walbert’s unwavering commitment...
by John Conrad | Feb 5, 2024 | iBIO News
Attention iBIO members! Struggling to access capital for your life sciences ventures? We’ve got exciting news! Introducing a new member-exclusive service: In partnership with G2G Consulting, we’re offering monthly reports and webinars to help you secure...
by John Conrad | Jan 27, 2023 | Member News
CHICAGO–(BUSINESS WIRE)–ClostraBio, a biotech company focused on developing novel therapeutic solutions for diseases of the gut, is excited to announce a major breakthrough in targeted metabolite delivery to transform intestinal health. This...
by John Conrad | Jan 19, 2023 | Member News
As Horizon ties up the loose ends for its $28 billion sale to Amgen, a drug it picked up from a previous acquisition of its own is delivering a mid-stage win. Horizon had already declared Phase II success for dazodalibep among one group of patients with Sjögren’s...